Sonnet BioTherapeutics Holdings, Inc. (SONN)
$1.26-59.35%Close
SELLCRISIS · day 9
Key stats
- Market cap
- $8M
- Beta
- 1.47
- P/E (TTM)
- -0.84
- 1W
- -74.02%
- 1M
- -74.90%
- vs SPY 1W
- -75.18%
- vs SPY 1M
- -77.89%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on SONN?
- LOPJLB’s latest quantitative signal on Sonnet BioTherapeutics Holdings, Inc. (SONN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SONN in?
- Sonnet BioTherapeutics Holdings, Inc. (SONN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Sonnet BioTherapeutics Holdings, Inc. (SONN) do?
- Sonnet BioTherapeutics Holdings, Inc., a biotechnology company based in Princeton, New Jersey, operates in the clinical stage with a primary focus on oncology. The firm is dedicated to developing novel platforms for creating biologic medicines that can exhibit either singular or dual therapeutic mechanisms. Central to their strategy is a proprietary fully human albumin binding technology. This …